½ÃÀ庸°í¼­
»óǰÄÚµå
1446551

¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м® º¸°í¼­ : Àç·á À¯Çüº°, ¿ëµµº°, è¹ö À¯Çüº°, Å©±âº°, Ä¡·á ¿µ¿ªº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

Pharmaceutical Cartridges Market Size, Share & Trends Analysis Report By Material Type, By Application, By Chamber Type, By Size, By Therapeutic Area, By End-Use, By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 300 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ÀǾàǰ īƮ¸®Áö ½ÃÀå ¼ºÀå ¹× µ¿Çâ :

¼¼°è ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 24¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 8.07%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¦¾à »ê¾÷ÀÇ ±Þ°ÝÇÑ ¼ºÀå, ÀÚ°¡ Åõ¾à ¾à¹° »ç¿ë Áõ°¡, ¿þ¾î·¯ºí ÀÎÁ§ÅÍ ¼ö¿ä Áõ°¡ µî ´Ù¾çÇÑ ¿äÀÎÀÌ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

¿þ¾î·¯ºí ÀÎÁ§ÅÍ´Â Àå½Ã°£¿¡ °ÉÃÄ ´Ù·®ÀÇ ¾à¹°À» Åõ¿©Çϱâ À§ÇØ ¼³°èµÇ¾úÀ¸¸ç, ¾à¹°ÀÇ ºÀÀÔ ¹× Åõ¿©¸¦ À§ÇØ ¹Ì¸® ä¿öÁø īƮ¸®Áö¸¦ »ç¿ëÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú È帧Àº ¿þ¾î·¯ºí ÀÎÁ§ÅÍ ½Ã½ºÅÛÀÇ °íÀ¯ÇÑ ¿ä±¸ »çÇ×À» ÃæÁ·Çϵµ·Ï Á¶Á¤µÈ ÀǾàǰ īƮ¸®ÁöÀÇ Çʿ伺À» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ä«Æ®¸®Áö´Â Á¤È®ÇÑ Åõ¾à Á¤È®µµ¸¦ Á¦°øÇϰí, ´Ù¾çÇÑ ¾à¹°°úÀÇ È£È¯¼ºÀ» º¸ÀåÇϸç, ¿À·£ ½Ã°£ µ¿¾È ¾à¹°ÀÇ ¾ÈÁ¤¼ºÀ» À¯ÁöÇÕ´Ï´Ù. Á¦¾àȸ»ç¿Í Á¦Á¶¾÷üµéÀº ¿þ¾î·¯ºí ÀÎÁ§ÅÍ¿¡ ÀûÇÕÇÑ ÀǾàǰÀ» °³¹ßÇÏ´Â °ÍÀ» ¿ì¼±¼øÀ§·Î »ï°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼¿¡ µû¶ó ÀÌ·¯ÇÑ Ã·´Ü ¾à¹° Àü´Þ ½Ã½ºÅÛÀÇ Æ¯Â¡ÀûÀÎ »ç¾ç¿¡ ¸Â´Â Àü¿ë īƮ¸®Áö¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, 2023³â 10¿ù Enable Injections´Â Çõ½ÅÀûÀÎ ¿þ¾î·¯ºí ÀÎÁ§ÅÍ Empaveli InjectorÀÇ FDA ½ÂÀÎÀ» ¹Þ¾Ò´Ù°í ¹àÇû½À´Ï´Ù. ÀÌ Ã·´Ü ¿þ¾î·¯ºí ±â±â´Â ¹ßÀÛ¼º ¾ß°£ Ç÷»ö¼Ò´¢ÁõÀ» ¾Î°í ÀÖ´Â ¼ºÀΠȯÀÚµéÀ» À§ÇØ Æ¯º°È÷ °í¾ÈµÈ Á¦Ç°ÀÔ´Ï´Ù. ÇÚÁîÇÁ¸®·Î ¾à¹°À» Àü´ÞÇÒ ¼ö ÀÖÀ¸¸ç, ÃÖ´ë 25ml±îÁö ÁÖÀÔÇÒ ¼ö ÀÖ½À´Ï´Ù. ´ÙÀç´Ù´ÉÇÑ µðÀÚÀÎÀ¸·Î °¡Á¤À̳ª ÀÓ»ó ÇöÀå¿¡¼­ ½±°Ô »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. À̹ø ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎÀº ÀÌ ÀåÄ¡ÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀ» °­Á¶ÇÏ´Â °ÍÀ¸·Î, ¹ßÀÛ¼º ¾ß°£ Ç÷»ö¼Ò´¢ÁõÀ¸·Î °íÅë¹Þ´Â ȯÀڵ鿡°Ô º¸´Ù °£ÆíÇϰí È¿°úÀûÀÎ Ä¡·á ÁßÀ縦 Á¦°øÇÔÀ¸·Î½á Å« µµ¿òÀÌ µÉ °ÍÀ¸·Î ±â´ëµË´Ï´Ù. ȯÀÚ Áß½ÉÀÇ ¾à¹° Àü´Þ ¼Ö·ç¼Ç, ±â¼ú ¹ßÀü, ¿þ¾î·¯ºí ÀÎÁ§ÅÍÀÇ º¸±Þ È®´ë°¡ ±³Â÷Çϸ鼭 Á¦¾à¾÷°èÀÇ »óȲÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù.

Á¦¾àȸ»ç¿Í īƮ¸®Áö Á¦Á¶¾÷üµéÀÌ º¯È­ÇÏ´Â ÀÇ·á ¼­ºñ½º ¼ö¿ä¿¡ ÀûÀÀÇϱâ À§ÇØ Àü·«À» ÀçÆíÇÔ¿¡ µû¶ó ÀÌ ½ÃÀåÀº Áö¼ÓÀûÀÎ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖÀ¸¸ç, ¿ªµ¿ÀûÀ̰í Çõ½ÅÀûÀÎ ÀÌ ºÐ¾ß¿¡¼­ Çõ½Å°ú Çù¾÷¿¡ ´ëÇÑ Ç³ºÎÇÑ Àü¸ÁÀ» Á¦½ÃÇÒ °ÍÀÔ´Ï´Ù. ¶ÇÇÑ, µðÁöÅÐ Çコ ±â¼ú°ú ¿þ¾î·¯ºí ÀÎÁ§ÅÍÀÇ À¶ÇÕÀº ¸ð´ÏÅ͸µ, ¼øÀÀµµ ¹× Àü¹ÝÀûÀΠȯÀÚ °á°ú¸¦ Çâ»ó½ÃŰ´Â ÀüÀÚ ½Ã½ºÅÛ°ú ÅëÇÕ °¡´ÉÇÑ ½º¸¶Æ® īƮ¸®Áö¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í Áõ°¡½ÃÄÑ »ê¾÷ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ÀǾàǰ īƮ¸®Áö ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ÇÃ¶ó½ºÆ½ īƮ¸®Áö ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR 8.93%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇÃ¶ó½ºÆ½Àº ±Ý¼Ó ¹× À¯¸®¿Í ºñ±³ÇÏ¿© °æ·®, °¡´Ü¼º, ºñ¿ë È¿À²¼º°ú °°Àº À¯¸®ÇÑ Æ¯¼ºÀ¸·Î ÀÎÇØ Æ÷Àå ¼Ö·ç¼Ç¿¡ ¼±È£µÇ°í ÀÖ½À´Ï´Ù.
  • ¿þ¾î·¯ºí ÀÎÁ§ÅÍ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR 9.33%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À̴ ȨÄɾ ´ëÇÑ ¼±È£µµ Áõ°¡¿Í ¾à¹° Àü´Þ ±â¼úÀÇ ¹ßÀü¿¡ ±âÀÎÇÕ´Ï´Ù.
  • µà¾ó è¹ö ºÎ¹®Àº ¹Î°¨ÇÑ »ý¹°ÇÐÀû Á¦Á¦ ¹× º¹ÀâÇÑ ¾à¹° Á¦Á¦ÀÇ º¸Á¸ ±â°£°ú È¿´ÉÀ» Çâ»ó½Ãų ¼ö Àֱ⠶§¹®¿¡ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR 8.61%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • 3ml ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR 9.26%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¦¾àȸ»çµéÀº °³º° ȯÀÚÀÇ ¿ä±¸¿¡ ¸Â´Â ¾à¹°À» °³¹ßÇϱâ À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸¸ç, 3ml īƮ¸®Áö Å©±â´Â ´Ù¾çÇÑ ¿ë·® ¿ä±¸ »çÇ×À» ÃæÁ·ÇÒ ¼ö ÀÖ´Â ¹ü¿ëÀûÀÎ ¼±ÅñÇÀ» Á¦°øÇÕ´Ï´Ù.
  • ´ç´¢º´ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR 9.69%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´ç´¢º´ À¯º´·ü Áõ°¡¿Í ³ë·É Àα¸ Áõ°¡°¡ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ±âŸ ÃÖÁ¾»ç¿ëÀÚ ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR 9.61%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÃÖÁ¾ »ç¿ëÀÚ ºÐ¾ß¿¡´Â »ý¸í°úÇÐ ±â¾÷, Çмú ±â°ü, Á¦¾à/ÃæÁø ¹× ¸¶°¨ ¼öŹ Á¦Á¶¾÷ü°¡ Æ÷ÇԵ˴ϴÙ.
  • ºÏ¹Ì´Â ÀÌ Áö¿ª¿¡¼­ īƮ¸®Áö¸¦ Á¦Á¶ÇÏ´Â Á¦¾àȸ»ç°¡ ¸¹±â ¶§¹®¿¡ 2023³â ÀǾàǰ īƮ¸®Áö ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : º¯¼ö, µ¿Çâ ¹× ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ½ÃÀå ±âȸ ºÐ¼®
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦ ºÐ¼®
  • ÀǾàǰ īƮ¸®Áö ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - PorterÀÇ Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : Àç·á À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, Àç·á À¯Çüº°, 2018-2030³â
  • À¯¸® īƮ¸®Áö
  • ÇÃ¶ó½ºÆ½ īƮ¸®Áö
  • °í¹«

Á¦5Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, ¿ëµµº°, 2018-2030³â
  • Ä¡°ú ¸¶Ãë
  • Ææ ÀÎÁ§ÅÍ
  • ÀÚ°¡ÁÖ»ç±â
  • ¿þ¾î·¯ºí ÀÎÁ§ÅÍ

Á¦6Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : è¹ö À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, è¹ö À¯Çüº°, 2018-2030³â
  • µà¾ó è¹ö
  • ´ë¿ë·®

Á¦7Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : »çÀÌÁî ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, »çÀÌÁ, 2018-2030³â
  • 0.5ml
  • 1.8ml
  • 2 ml-2.5ml
  • 3ml
  • 5ml
  • 10ml ÀÌ»ó

Á¦8Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : Ä¡·á ¿µ¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, Ä¡·á ¿µ¿ªº°, 2018-2030³â
  • ¾È°ú
  • È£Èí±â
  • ½Å°æ
  • Á¾¾ç
  • ¸é¿ª
  • ½ÉÀ庴
  • ´ç´¢º´
  • Ä¡°ú
  • ±âŸ

Á¦9Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ ÀǾàǰ īƮ¸®Áö ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, ÃÖÁ¾ ¿ëµµº°, 2018-2030³â
  • ÀǾàǰ
  • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö
  • ¿¬±¸±â°ü
  • ±âŸ

Á¦10Àå ÀǾàǰ īƮ¸®Áö ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®, Àç·á À¯Çüº°, ¿ëµµº°, è¹ö À¯Çüº°, »çÀÌÁ, Ä¡·á ¿µ¿ªº°, ÃÖÁ¾ ¿ëµµº°

  • Áö¿ª ´ë½Ãº¸µå
  • 2018³âºÎÅÍ 2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå ÁøÃâ±â¾÷ ºÐ·ù
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Stevanato Group
    • NIPRO
    • Gerresheimer AG
    • West Pharmaceutical Services, Inc.
    • Schott AG
    • Transcoject GmbH
    • Shandong Medicinal Glass Co., Ltd.
    • Datwyler Holding Inc.
    • AptarGroup, Inc.
    • Sonata Rubber
  • È÷Æ®¸Ê ºÐ¼®/±â¾÷ ½ÃÀå ÇöȲ ºÐ¼®
  • ÃßÁ¤ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • ±âŸ ÁÖ¿ä ½ÃÀå ±â¾÷ ¸®½ºÆ®
LSH 24.03.27

Pharmaceutical Cartridges Market Growth & Trends:

The global pharmaceutical cartridges market size is anticipated to reach USD 2.43 billion by 2030 and is anticipated to expand at a CAGR of 8.07% from 2024 to 2030. The market is driven by various factors such as rapid growth in the pharmaceutical industry, increasing use of self-administered medications, and rising demand for wearable injectors.

Wearable injectors are designed for dispensing substantial drug volumes over prolonged periods and frequently employ pre-filled cartridges for containment and administration of medications. This trajectory in technology amplifies the need for pharmaceutical cartridges tailored to meet the distinctive demands of wearable injector systems. Such cartridges provide exact dosing precision, assure compatibility with diverse drugs, and sustain the stability of medications throughout extended durations. Pharmaceutical companies and manufacturers are progressively prioritizing the development of pharmaceuticals compatible with wearable injectors. This trend has led to heightened demand for specialized cartridges tailored to meet the distinctive specifications of these advanced drug delivery systems.

For instance, in October 2023, Enable Injections revealed the FDA approval for its innovative wearable injector, Empaveli Injector. This advanced wearable device is specifically designed for the adult demographic with paroxysmal nocturnal hemoglobinuria. It offers a hands-free drug delivery mechanism, accommodating a volume of up to 25 ml. Its versatile design facilitates utilization both within the confines of one's home and in clinical settings. This regulatory endorsement underscores the device's efficacy and safety, significantly empowering individuals grappling with paroxysmal nocturnal hemoglobinuria through enhanced and convenient therapeutic interventions. The intersection of patient-centric drug delivery solutions, technological advancements, and the rising prevalence of wearable injectors is molding the landscape of pharmaceutical industry.

As pharmaceutical companies and cartridge manufacturers realign their strategies to adapt to changing demands of healthcare delivery, the market is set for sustained growth, presenting abundant prospects for innovation and collaboration in this dynamic and transformative sector. Additionally, the convergence of digital health technologies with wearable injectors is further amplifying the demand for smart cartridges capable of integrating with electronic systems to enhance monitoring, adherence, and overall patient outcomes thus propelling the industry growth.

Pharmaceutical Cartridges Market Report Highlights:

  • Plastic cartridges segment is expected to register the fastest CAGR of 8.93% during the forecast period. Plastic is preferred for packaging solutions due to its favorable characteristics, including low weight, malleability, and cost-effectiveness, in comparison to metal and glass
  • Wearable injectors segment is expected to register the fastest CAGR of 9.33% during the forecast period. This is due to the growing preference for homecare settings and advancements in drug delivery technologies
  • Dual chamber segment is expected to register the fastest CAGR of 8.61% during the forecast period owing its ability to enhance the shelf life and efficacy of sensitive biologics and complex drug formulations
  • 3ml segment is expected to register the fastest CAGR of 9.26% during the forecast period. Pharmaceutical companies are increasingly developing drugs tailored to individual patient needs, and 3ml cartridge size provides a versatile option for accommodating varying dosage requirements
  • Diabetes segment is expected to register the fastest CAGR of 9.69% during the forecast period. Increasing incidence of diabetes coupled with rising geriatric population drive the segment growth
  • Others end-use segment is expected to register the fastest CAGR of 9.61% during the forecast period. Other end-users segment includes life sciences companies, academic institutes, and drug product/ fill & finish contract manufacturers
  • North America dominated the pharmaceutical cartridges market in 2023 owing to the presence of majority of pharmaceutical companies manufacturing cartridges in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Cartridges Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rapid Growth In The Global Pharmaceutical Industry
      • 3.2.1.2. Growing Demand For Drug Delivery Devices
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Challenges Associated With Glass Surface
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Rising Preference For Injectable Drug Formulations
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Stringent Regulatory Framework
  • 3.3. Pharmaceutical Cartridges Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Pharmaceutical Cartridges Market: Material Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Pharmaceutical Cartridges Market Movement Analysis
  • 4.3. Global Pharmaceutical Cartridges Market Size & Trend Analysis, by Material Type, 2018 to 2030 (USD Million)
  • 4.4. Glass Cartridges
    • 4.4.1. Glass Cartridges Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Type 1
      • 4.4.2.1. Type 1 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Type 2
      • 4.4.3.1. Type 2 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Type 3
      • 4.4.4.1. Type 3 Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Plastic Cartridges
    • 4.5.1. Plastic Cartridges Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Polypropylene (PP)
      • 4.5.2.1. Polypropylene (PP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Cyclic Olefin Copolymer (COC)
      • 4.5.3.1. Cyclic Olefin Copolymer (COC) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Cyclic Olefin Polymer (COP)
      • 4.5.4.1. Cyclic Olefin Polymer (COP) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Polyethylene
      • 4.5.5.1. Polyethylene Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Rubber
    • 4.6.1. Rubber Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Cartridges Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Pharmaceutical Cartridges Market Movement Analysis
  • 5.3. Global Pharmaceutical Cartridges Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Dental Anesthesia
    • 5.4.1. Dental Anesthesia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Pen Injectors
    • 5.5.1. Pen Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Autoinjectors
    • 5.6.1. Autoinjectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Wearable Injectors
    • 5.7.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Cartridges Market: Chamber Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Pharmaceutical Cartridges Market Movement Analysis
  • 6.3. Global Pharmaceutical Cartridges Market Size & Trend Analysis, by Chamber Type, 2018 to 2030 (USD Million)
  • 6.4. Dual Chamber
    • 6.4.1. Dual Chamber Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Large Volume
    • 6.5.1. Large Volume Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pharmaceutical Cartridges Market: Size Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Pharmaceutical Cartridges Market Movement Analysis
  • 7.3. Global Pharmaceutical Cartridges Market Size & Trend Analysis, by Size, 2018 to 2030 (USD Million)
  • 7.4. 0.5 ml
    • 7.4.1. 0.5ml Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. 1.8 ml
    • 7.5.1. 1.8ml Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. 2ml to 2.5 ml
    • 7.6.1. 2ml to 2.5 ml Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. 3 ml
    • 7.7.1. 3ml Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. 5 ml
    • 7.8.1. 5ml Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. More than 10 ml
    • 7.9.1. More than 10 ml Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Pharmaceutical Cartridges Market: Therapeutic Area Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Pharmaceutical Cartridges Market Movement Analysis
  • 8.3. Global Pharmaceutical Cartridges Market Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
  • 8.4. Ophthalmology
    • 8.4.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Respiratory
    • 8.5.1. Respiratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Neurology
    • 8.6.1. Neurology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Oncology
    • 8.7.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8. Immunology
    • 8.8.1. Immunology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9. Cardiology
    • 8.9.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.10. Diabetes
    • 8.10.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.11. Dental
    • 8.11.1. Dental Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.12. Others
    • 8.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Pharmaceutical Cartridges Market: End Use Estimates & Trend Analysis

  • 9.1. Segment Dashboard
  • 9.2. Global Pharmaceutical Cartridges Market Movement Analysis
  • 9.3. Global Pharmaceutical Cartridges Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 9.4. Pharmaceutical
    • 9.4.1. Pharmaceutical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.5. Biotechnology
    • 9.5.1. Biotechnology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.6. Research Organizations
    • 9.6.1. Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 9.7. Others
    • 9.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 10. Pharmaceutical Cartridges Market: Regional Estimates & Trend Analysis By Material Type, By Application, By Chamber Type, By Size, By Therapeutic Area, By End-use

  • 10.1. Regional Dashboard
  • 10.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 10.3. North America
    • 10.3.1. North America Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.3.2. U.S.
      • 10.3.2.1. Key Country Dynamics
      • 10.3.2.2. Competitive Scenario
      • 10.3.2.3. Regulatory Scenario
      • 10.3.2.4. Reimbursement Scenario
      • 10.3.2.5. U.S. Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.3.3. Canada
      • 10.3.3.1. Key Country Dynamics
      • 10.3.3.2. Competitive Scenario
      • 10.3.3.3. Regulatory Scenario
      • 10.3.3.4. Reimbursement Scenario
      • 10.3.3.5. Canada Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.4. Europe
    • 10.4.1. Europe Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.2. UK
      • 10.4.2.1. Key Country Dynamics
      • 10.4.2.2. Competitive Scenario
      • 10.4.2.3. Regulatory Scenario
      • 10.4.2.4. Reimbursement Scenario
      • 10.4.2.5. UK Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.3. Germany
      • 10.4.3.1. Key Country Dynamics
      • 10.4.3.2. Competitive Scenario
      • 10.4.3.3. Regulatory Scenario
      • 10.4.3.4. Reimbursement Scenario
      • 10.4.3.5. Germany Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.4. France
      • 10.4.4.1. Key Country Dynamics
      • 10.4.4.2. Competitive Scenario
      • 10.4.4.3. Regulatory Scenario
      • 10.4.4.4. Reimbursement Scenario
      • 10.4.4.5. France Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.5. Italy
      • 10.4.5.1. Key Country Dynamics
      • 10.4.5.2. Competitive Scenario
      • 10.4.5.3. Regulatory Scenario
      • 10.4.5.4. Reimbursement Scenario
      • 10.4.5.5. Italy Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.6. Spain
      • 10.4.6.1. Key Country Dynamics
      • 10.4.6.2. Competitive Scenario
      • 10.4.6.3. Regulatory Scenario
      • 10.4.6.4. Reimbursement Scenario
      • 10.4.6.5. Spain Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.7. Denmark
      • 10.4.7.1. Key Country Dynamics
      • 10.4.7.2. Competitive Scenario
      • 10.4.7.3. Regulatory Scenario
      • 10.4.7.4. Reimbursement Scenario
      • 10.4.7.5. Denmark Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.8. Sweden
      • 10.4.8.1. Key Country Dynamics
      • 10.4.8.2. Competitive Scenario
      • 10.4.8.3. Regulatory Scenario
      • 10.4.8.4. Reimbursement Scenario
      • 10.4.8.5. Sweden Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.4.9. Norway
      • 10.4.9.1. Key Country Dynamics
      • 10.4.9.2. Competitive Scenario
      • 10.4.9.3. Regulatory Scenario
      • 10.4.9.4. Reimbursement Scenario
      • 10.4.9.5. Norway Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.5. Asia Pacific
    • 10.5.1. Asia Pacific Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.2. Japan
      • 10.5.2.1. Key Country Dynamics
      • 10.5.2.2. Competitive Scenario
      • 10.5.2.3. Regulatory Scenario
      • 10.5.2.4. Reimbursement Scenario
      • 10.5.2.5. Japan Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.3. China
      • 10.5.3.1. Key Country Dynamics
      • 10.5.3.2. Competitive Scenario
      • 10.5.3.3. Regulatory Scenario
      • 10.5.3.4. Reimbursement Scenario
      • 10.5.3.5. China Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.4. India
      • 10.5.4.1. Key Country Dynamics
      • 10.5.4.2. Competitive Scenario
      • 10.5.4.3. Regulatory Scenario
      • 10.5.4.4. Reimbursement Scenario
      • 10.5.4.5. India Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.5. South Korea
      • 10.5.5.1. Key Country Dynamics
      • 10.5.5.2. Competitive Scenario
      • 10.5.5.3. Regulatory Scenario
      • 10.5.5.4. Reimbursement Scenario
      • 10.5.5.5. South Korea Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.6. Australia
      • 10.5.6.1. Key Country Dynamics
      • 10.5.6.2. Competitive Scenario
      • 10.5.6.3. Regulatory Scenario
      • 10.5.6.4. Reimbursement Scenario
      • 10.5.6.5. Australia Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.5.7. Thailand
      • 10.5.7.1. Key Country Dynamics
      • 10.5.7.2. Competitive Scenario
      • 10.5.7.3. Regulatory Scenario
      • 10.5.7.4. Reimbursement Scenario
      • 10.5.7.5. Thailand Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.6. Latin America
    • 10.6.1. Latin America Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.6.2. Brazil
      • 10.6.2.1. Key Country Dynamics
      • 10.6.2.2. Competitive Scenario
      • 10.6.2.3. Regulatory Scenario
      • 10.6.2.4. Reimbursement Scenario
      • 10.6.2.5. Brazil Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.6.3. Mexico
      • 10.6.3.1. Key Country Dynamics
      • 10.6.3.2. Competitive Scenario
      • 10.6.3.3. Regulatory Scenario
      • 10.6.3.4. Reimbursement Scenario
      • 10.6.3.5. Mexico Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.6.4. Argentina
      • 10.6.4.1. Key Country Dynamics
      • 10.6.4.2. Competitive Scenario
      • 10.6.4.3. Regulatory Scenario
      • 10.6.4.4. Reimbursement Scenario
      • 10.6.4.5. Argentina Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 10.7. Middle East & Africa
    • 10.7.1. Middle East & Africa Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.7.2. South Africa
      • 10.7.2.1. Key Country Dynamics
      • 10.7.2.2. Competitive Scenario
      • 10.7.2.3. Regulatory Scenario
      • 10.7.2.4. Reimbursement Scenario
      • 10.7.2.5. South Africa Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.7.3. Saudi Arabia
      • 10.7.3.1. Key Country Dynamics
      • 10.7.3.2. Competitive Scenario
      • 10.7.3.3. Regulatory Scenario
      • 10.7.3.4. Reimbursement Scenario
      • 10.7.3.5. Saudi Arabia Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.7.4. UAE
      • 10.7.4.1. Key Country Dynamics
      • 10.7.4.2. Competitive Scenario
      • 10.7.4.3. Regulatory Scenario
      • 10.7.4.4. Reimbursement Scenario
      • 10.7.4.5. UAE Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 10.7.5. Kuwait
      • 10.7.5.1. Key Country Dynamics
      • 10.7.5.2. Competitive Scenario
      • 10.7.5.3. Regulatory Scenario
      • 10.7.5.4. Reimbursement Scenario
      • 10.7.5.5. Kuwait Pharmaceutical Cartridges Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 11. Competitive Landscape

  • 11.1. Market Participant Categorization
  • 11.2. Key Company Profiles
    • 11.2.1. Stevanato Group
      • 11.2.1.1. Company Overview
      • 11.2.1.2. Financial Performance
      • 11.2.1.3. Service Benchmarking
      • 11.2.1.4. Strategic Initiatives
    • 11.2.2. NIPRO
      • 11.2.2.1. Company Overview
      • 11.2.2.2. Financial Performance
      • 11.2.2.3. Service Benchmarking
      • 11.2.2.4. Strategic Initiatives
    • 11.2.3. Gerresheimer AG
      • 11.2.3.1. Company Overview
      • 11.2.3.2. Financial Performance
      • 11.2.3.3. Service Benchmarking
      • 11.2.3.4. Strategic Initiatives
    • 11.2.4. West Pharmaceutical Services, Inc.
      • 11.2.4.1. Company Overview
      • 11.2.4.2. Financial Performance
      • 11.2.4.3. Service Benchmarking
      • 11.2.4.4. Strategic Initiatives
    • 11.2.5. Schott AG
      • 11.2.5.1. Company Overview
      • 11.2.5.2. Financial Performance
      • 11.2.5.3. Service Benchmarking
      • 11.2.5.4. Strategic Initiatives
    • 11.2.6. Transcoject GmbH
      • 11.2.6.1. Company Overview
      • 11.2.6.2. Financial Performance
      • 11.2.6.3. Service Benchmarking
      • 11.2.6.4. Strategic Initiatives
    • 11.2.7. Shandong Medicinal Glass Co., Ltd.
      • 11.2.7.1. Company Overview
      • 11.2.7.2. Financial Performance
      • 11.2.7.3. Service Benchmarking
      • 11.2.7.4. Strategic Initiatives
    • 11.2.8. Datwyler Holding Inc.
      • 11.2.8.1. Company Overview
      • 11.2.8.2. Financial Performance
      • 11.2.8.3. Service Benchmarking
      • 11.2.8.4. Strategic Initiatives
    • 11.2.9. AptarGroup, Inc.
      • 11.2.9.1. Company Overview
      • 11.2.9.2. Financial Performance
      • 11.2.9.3. Service Benchmarking
      • 11.2.9.4. Strategic Initiatives
    • 11.2.10. Sonata Rubber
      • 11.2.10.1. Company Overview
      • 11.2.10.2. Financial Performance
      • 11.2.10.3. Service Benchmarking
      • 11.2.10.4. Strategic Initiatives
  • 11.3. Heat Map Analysis/ Company Market Position Analysis
  • 11.4. Estimated Company Market Share Analysis, 2023
  • 11.5. List of Other Key Market Players
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦